An MIT Sloan alum explains why she pursued an MBA to pivot from biomedical research into healthcare strategy and policy. The essay details program selection criteria—school reputation, healthcare focus, entrepreneurship opportunities—and how Sloan’s flexibility allowed cross-disciplinary learning. The author frames the MBA as a tool for career resets, capability-building and access to networks that support roles in healthcare companies, global health NGOs, or health-focused startups. The piece offers a practitioner view on when an MBA adds strategic value to clinical or life-science backgrounds.